Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (taps-2): statistical and qualitative analysis plan for a randomised controlled feasibility trial

HIGHLIGHTS

• who: Paul T. Seed from the Trial recruitment and data collection Pregnant women with SCD who potentially meet the inclusion criteria [4] will be provided with the Patient Information Sheet (PIS) and invited to meet with the site research practitionerWritten informed consent will be obtained by one of the trial physicians or practitioners. Baseline data collection will include current and previous medical and obstetric history and socio-demographic information. Information on maternal, sickle and foetal complications will be collected every , to , weeks during pregnancy. Health economic data will be collected at least once each trimester and postnatally . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.